ortho-Metalation of Enantiopure Aromatic Sulfoxides
chromatography (silica gel with Et2O/cyclohexane (4/1) as eluent)
a mixture of two diastereoisomers (ratio 80:20 determined by H
NMR). A subsequent purification by column chromatography (silica
gel with dichloromethane/ethyl acetate (9/1) as eluent) gave in a
first fraction the major diastereoisomer 11a (243 mg, 50%) as a
white solid, mp 160 °C. The ee was 99% by HPLC (Chiralpak AD
(C); 142.6 (C); 141.0 (C); 138.7 (C); 133.3 (C); 133.0 (CH); 132.4
(C); 129.7 (C); 129.6 (CH); 128.8 (CH); 128.7 (CH); 127.5 (CH);
127.3 (CH); 127.1 (CH); 126.8 (CH); 126.5 (CH); 126.0 (CH);
124.6 (CH); 60.0 (C); 57.4 (CH); 25.4 (CH3); 21.3 (CH3). IR (KBr)
(cm-1): 2786-3027, 1340, 1163, 1007. Anal. Calcd for C28H29-
NO3S2: C, 68.40; H, 5.94; N, 2.85; S, 13.04. Found: C, 68.10; H,
6.12; N, 3.04; S, 12.79.
1
column, 1 mL/min, 80:20 heptane/i-PrOH, λ ) 230 nm, t1R,(S)R
)
15.4 min, t1S,(S)S ) 18.7 min). [R]20D ) -149 (c 0.68, CHCl3). 1H
NMR (CDCl3): δ 7.79 (m, 1H); 7.67 (m, 1H); 7.52 (d, J ) 8.3
Hz, 2H); 7.37 (m, 2H); 7.10 (d, J ) 7.9 Hz, 2H); 7.03 (m, 3H);
6.92 (m, 2H); 6.10 (d, J ) 6.8 Hz, 1H); 6.01 (d, J ) 6.8 Hz, 1H);
2.36 (s, 3H); 1.22 (s, 9). 13C NMR (CDCl3): δ 143.4 (C); 140.6
(C); 139.6 (C); 137.5 (C); 131.7 (CH); 129.4 (CH); 128.7 (CH);
128.0 (CH); 127.8 (CH); 127.4 (CH); 127.1 (CH); 127.0 (CH);
126.8 (CH); 58.0 (CH); 57.8 (C); 23.2 (CH3); 21.5 (CH3). IR (KBr)
(cm-1): 2868-3085, 1458, 1332, 1160, 1003, 670. Anal. Calcd
for C24H27NO3S2: C, 65.28; H, 6.16; N, 3.17; S, 14.52. Found: C,
65.51; H, 5.64; N, 2.96; S, 12.80.
[1S,(S)S]-(-)-N-[2-Methyl-1-(1-tert-butylsulfinylnaphthalen-
2-yl)propyl]-4-methylbenzenesulfonamide (14). Metalation of 2
(0.15 g, 0.65 mmol) according to the general procedure for direct
lithiation with 2.5 M n-BuLi (0.83 mL, 2.07 mmol) and TMPH
(0.35 mL, 2.07 mmol), followed by reaction with the sulfonylimine
10 (R ) i-Pr) (0.47 g, 2.1 mmol), gave after purification by column
chromatography (silica gel with dichloromethane/acetone (95/5) as
eluent) 14 (197 mg, 66%) as a single diastereoisomer (ratio >99:1
determined by 1H NMR) and as a white solid, mp 170 °C. The ee
was 99% by HPLC (Chiralpak AD column, 1 mL/min, 80:20
heptane/i-PrOH, λ ) 230 nm, t1R,(S)R ) 14.4 min, t1S,(S)S ) 17.8
1
A second fraction gave the minor diastereoisomer 11b (62 mg,
13%) as a white solid, mp 160 °C. The ee was 99% by HPLC
(Chiralpak AD column, 1 mL/min, 80:20 heptane/i-PrOH, λ ) 230
nm, t1R,(S)S ) 15.6 min, t1S,(S)R ) 19.8 min). [R]20D ) -135 (c 0.93,
min). [R]20 ) -157 (c 0.29, CHCl3). H NMR (CDCl3): δ 9.34
D
(m, 1H); 7.69 (m, 4H); 7.51 (d, J ) 8.7 Hz, 1H); 7.41 (m, 2H);
7.15 (d, J ) 8.3 Hz, 2H); 5.75 (d, J ) 8.3 Hz, 1H); 5.22 (m, 1H);
2.31 (m, 4H); 1.24 (s, 9H); 0.82 (d, J ) 6.8 Hz, 3H); 0.55 (d, J )
6.8 Hz, 3H). 13C NMR (CDCl3): δ 143.9 (C); 143.4 (C); 138.3
(C); 133.8 (C); 133.6 (C); 132.4 (CH); 130.4 (C); 129.9 (CH); 128.6
(CH); 127.3 (CH); 127.2 (CH); 126.9 (CH); 126.9 (CH); 124.1
(CH); 61.0 (C); 59.6 (CH); 36.0 (CH); 26.2 (CH3); 21.9 (CH3);
20.7 (CH3); 15.8 (CH3). IR (KBr) (cm-1): 3140, 2898-2965, 1474,
1330, 1162, 1095, 1045, 1012, 670. Anal. Calcd for C25H31NO3S2:
C, 65.61; H, 6.83; N, 3.06; S, 14.01. Found: C, 66.06; H, 6.97; N,
3.08; S, 14.45.
1
CHCl3). H NMR (CDCl3): δ 7.67 (d, J ) 8.3 Hz, 1H); 7.47 (d,
J ) 8.3 Hz, 2H); 7.25 (m, 8H); 7.05 (d, J ) 8.3 Hz, 2H); 6.07 (d,
J ) 6.8 Hz, 1H); 5.39 (d, J ) 6.8 Hz, 1H); 2.28 (s, 3H); 0.89 (s,
9H). 13C NMR (CDCl3): δ 143.5 (C); 139.9 (C); 139.7 (C); 139.3
(C); 137.2 (C); 131.6 (CH); 129.9 (CH); 129.5 (CH); 129.0 (CH);
128.9 (CH); 128.4 (CH); 128.4 (CH); 127.6 (CH); 127.5 (CH); 57.5
(C); 56.5 (CH); 23.5 (CH3); 21.9 (CH3). IR (KBr) (cm-1): 2922-
3253, 1440, 1328, 1159, 1057, 1028, 669. Anal. Calcd for C24H27-
NO3S2: C, 65.28; H, 6.16; N, 3.17; S, 14.52. Found: C, 64.97; H,
6.47; N, 2.92; S, 12.96.
[1S,(S)S]-(-)-N-[(3-tert-Butylsulfinylpyridin-4-yl)phenylmethyl]-
4-methylbenzenesulfonamide (15). Metalation of 3 (0.15 g, 0.82
mmol) according to the general procedure for direct lithiation with
2.5 M n-BuLi (0.72 mL, 1.8 mmol) and DIPAH (0.25 mL, 1.8
mmol), followed by reaction with the sulfonylimine 9 (R ) Ph)
(0.52 g, 2 mmol), gave after purification by column chromatography
(silica gel with ethyl acetate as eluent) 15 (287 mg, 79%) as a single
[1S,(S)S]-(-)-N-[2-Methyl-1-(2-tert-butylsulfinylphenyl)-
propyl]-4-methylbenzenesulfonamide (12). Metalation of 1 (0.15
g, 0.82 mmol) according to the general procedure for direct lithiation
with 1.6 M n-BuLi (0.62 mL, 0.99 mmol), followed by reaction
with the sulfonylimine 10 (R ) i-Pr) (0.27 g, 1.2 mmol), gave after
purification by column chromatography (silica gel with Et2O as
eluent) 12 (264 mg, 80%) as a single diastereoisomer (ratio >99:1
1
diastereoisomer (ratio >99:1 determined by H NMR) and as a
pale yellow solid, mp 100 °C. The ee was 99% by HPLC (Chiralpak
AD column, 1 mL/min, 75:25 heptane/i-PrOH, λ ) 230 nm, t1R,(S)R
) 9.9 min, t1S,(S)S ) 12.4 min). [R]20D ) -65 (c 1.17, CHCl3). 1H
NMR (CDCl3): δ 8.83 (s, 1H); 8.61 (d, J ) 4.9 Hz, 1H); 7.64 (d,
J ) 5.3 Hz, 1H); 7.52 (d, J ) 8.3 Hz, 2H); 7.15 (m, 6H); 6.77 (d,
J ) 7.5 Hz, 2H); 5.76 (d, J ) 6.0 Hz, 1H); 5.58 (d, J ) 6.0 Hz,
1H); 2.37 (s, 3H); 1.21 (s, 9H). 13C NMR (CDCl3): δ 152.7 (CH);
149.6 (C); 149.2 (CH); 144.5 (C); 138.1 (C); 137.3 (C); 133.9 (C);
130.1 (CH); 129.7 (CH); 129.2 (CH); 128.0 (CH); 127.5 (CH);
121.3 (CH); 58.6 (C); 58.4 (CH); 23.4 (CH3); 22.0 (CH3). IR (KBr)
(cm-1): 2861-3061, 1720, 1333, 1166, 1089, 1027, 577. Anal.
Calcd for C23H26N2O3S2: C, 62.42; H, 5.92; N, 6.33; S, 14.49.
Found: C, 62.74; H, 5.89; N, 6.41; S, 14.56.
1
determined by H NMR) and as a white solid, mp 70 °C. The ee
was 99% by HPLC (Chiralpak AD column, 1 mL/min, 80:20
heptane/i-PrOH, λ ) 230 nm, t1S,(S)S ) 10.7 min, t1R,(S)R ) 12.2
1
min). [R]20 ) -150 (c 0.99, CHCl3). H NMR (CDCl3): δ 7.78
D
(d, J ) 7.7 Hz, 1H); 7.64 (d, J ) 8.3 Hz, 2H); 7.33 (m, 3H); 7.12
(d, J ) 8.3 Hz, 2H); 5.75 (d, J ) 7.5 Hz, 1H); 4.74 (dd, J ) 7.9
and 3.4 Hz, 1H); 2.33 (s, 3H); 2.17 (m, 1H); 1.14 (s, 9H); 0.78 (d,
J ) 6.8 Hz, 3H); 0.55 (d, J ) 6.8 Hz, 3H). 13C NMR (CDCl3): δ
143.8 (C); 141.6 (C); 138.3 (C); 137.8 (C); 131.4 (CH); 129.9 (CH);
127.9 (CH); 127.3 (CH); 127.3 (CH); 127.0 (CH); 59.4 (CH); 57.9
(C); 34.8 (CH); 23.5 (CH3); 21.9 (CH3); 20.4 (CH3); 15.5 (CH3).
IR (KBr) (cm-1): 2894-3138, 1459, 1323, 1158, 1017, 662. Anal.
Calcd for C21H29NO3S2: C, 61.88; H, 7.17; N, 3.44; S, 15.73.
Found: C, 61.89; H, 7.29; N, 3.61; S, 15.42.
[1S,(S)S]-(-)-N-[2-Methyl-1-(3-tert-butylsulfinylpyridin-4-yl)-
propyl]-4-methylbenzenesulfonamide (16). Metalation of 3 (0.15
g, 0.82 mmol) according to the general procedure for direct lithiation
with 2.5 M n-BuLi (0.72 mL, 1.8 mmol) and DIPAH (0.25 mL,
1.8 mmol), followed by reaction with the sulfonylimine 10 (R )
i-Pr) (0.45 g, 2 mmol), gave after purification by column chroma-
tography (silica gel with ethyl acetate as eluent) 16 (223 mg, 67%)
[1S,(S)S]-(-)-N-[(1-tert-Butylsulfinylnaphthalen-2-yl)phenyl-
methyl]-4-methylbenzenesulfonamide (13). Metalation of 2 (0.15
g, 0.65 mmol) according to the general procedure for direct lithiation
with 2.5 M n-BuLi (0.83 mL, 2.07 mmol) and TMPH (0.35 mL,
2.07 mmol), followed by reaction with the sulfonylimine 9 (R )
Ph) (0.59 g, 2.28 mmol), gave after purification by column
chromatography (silica gel with dichloromethane/Et2O (9/1) as
eluent) 13 (203 mg, 64%) as a single diastereoisomer (ratio >99:1
determined by 1H NMR) and as a white solid, mp 210 °C. The ee
was 99% by HPLC (Chiralpak AD column, 1 mL/min, 80:20
1
as a single diastereoisomer (ratio >99:1 determined by H NMR)
and as a pale yellow solid, mp 170 °C. The ee was 99% by HPLC
(Chiralpak AD column, 1 mL/min, 80:20 heptane/i-PrOH, λ ) 230
nm, t1R,(S)R ) 9.8 min, t1S,(S)S ) 18.3 min). [R]20D ) -118 (c 1.01,
1
CHCl3). H NMR (CDCl3): δ 9.14 (s, 1H); 8.74 (d, J ) 5.3 Hz,
heptane/i-PrOH, λ ) 230 nm, t1R,(S)R ) 31.9 min, t1S,(S)S ) 36.0
1H); 7.85 (d, J ) 8.3 Hz, 2H); 7.57 (d, J ) 4.9 Hz, 1H); 7.41 (d,
J ) 7.9 Hz, 2H); 6.49 (d, J ) 7.9 Hz, 1H); 4.83 (m, 1H); 2.57 (s,
3H); 2.47 (m, 1H); 1.43 (s, 9H); 1.07 (d, J ) 6.8 Hz, 3H); 0.79 (d,
J ) 6.8 Hz, 3H). 13C NMR (CDCl3): δ 152.1 (CH); 151.0 (C);
149.0 (CH); 144.2 (C); 137.7 (C); 133.7 (C); 130.0 (CH); 127.3
(CH); 121.4 (CH); 59.2 (CH); 58.4 (C); 34.1 (CH); 23.4 (CH3);
1
min). [R]20 ) -142 (c 0.65, DMSO). H NMR (DMSO-d6): δ
D
9.07 (d, J ) 8.7 Hz, 1H); 8.77 (m, 1H); 7.90 (d, J ) 8.7 Hz, 1H);
7.71 (d, J ) 7.2 Hz, 1H); 7.64 (d, J ) 8.7 Hz, 1H); 7.32 (m, 4H);
7.00 (d, J ) 7.9 Hz, 2H); 6.90 (m, 3H); 6.82 (m, 2H); 6.28 (m,
1H); 2.08 (s, 3H); 1.01 (s, 9H). 13C NMR (DMSO-d6): δ 142.9
J. Org. Chem, Vol. 71, No. 7, 2006 2615